News
Recent milestones across the Huang Lab’s academic and translational work.
Feb 25, 2026
The Huang Lab received support to advance preclinical development of PH102 for hepatocellular carcinoma, reinforcing the lab’s translational focus.
Read articleOct 1, 2025
Vincent Pham will present Huang Lab research at the 2025 San Antonio Liver Cancer Symposium.
Read articleSep 10, 2025
Dr. Gang Huang will present the lab’s latest work on PH102 at the 2025 La Frontera Symposium.
Read articleAug 1, 2025
The lab published a new review linking mitophagy to cancer and neurodegenerative disease biology and future therapies.
Read articleJul 2, 2025
The lab received new support from the Owens Medical Research Foundation to advance ongoing research priorities.
Read articleJun 6, 2025
A collaborative multi-program grant will support work on mitophagy’s role in adipose tissue depletion during cancer-associated cachexia.
Read articleApr 2, 2025
Vincent Pham will present new preclinical findings from the Huang Lab at AACR 2025 in Chicago.
Read articleJan 9, 2025
A new Journal of Clinical Investigation paper defines an essential role for CPT1A in hematopoietic stem cell maintenance.
Read articleDec 1, 2024
The lab will present new findings in hematopoietic stem cell biology and therapeutic mechanisms at ASH 2024.
Read articleOct 9, 2024
The Morrison Trust selected the Huang Lab for funding on mechanisms of tumor-derived lactate in cancer-associated cachexia.
Read articleOct 9, 2024
Vincent Pham joined the inaugural cohort of the NCI T32 EDGe Training Program in Cancer.
Read articleSep 30, 2024
The lab will present new preclinical PH102 data at the 2024 San Antonio Liver Cancer Symposium.
Read articleSep 9, 2024
The lab published a review in Frontiers in Immunology on the immune imbalance underlying cytokine storm syndromes.
Read articleAug 4, 2024
Powerhouse Therapeutics was formed to advance PH102 and selected solid-tumor cell therapy programs toward the clinic.
Read article